Compare Dolby Laboratories, Inc. (DLB) vs Centrus Energy Corp (LEU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Centrus Energy Corp — how do they compare? Dolby Laboratories, Inc. trades at $58.9 (market cap $5.47B), while Centrus Energy Corp trades at $144.21 (market cap $2.91B). The key difference: Dolby Laboratories, Inc. is the larger of the two by market cap, and Dolby Laboratories, Inc. pays a 2.46% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Centrus Energy Corp for 29 Days on average.
| DLB | LEU | |
|---|---|---|
Market Cap | $5.47B | $2.91B |
Volume | 1,058,284 | 903,777 |
Sector | Technology | Energy |
52-Week High | $70.09 | $436.00 |
52-Week Low | $48.51 | $138.18 |
Typical Hold Time | 98 Days | 29 Days |
Enterprise Value | $4.85B | $2.22B |
Dividend Yield | 2.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals. The company maintains strong profitability with 87.61% gross margins and has beaten earnings estimates for three consecutive quarters. Recent developments include expanded partnerships with Meta and leadership transition to new CEO Marc Whitten. Cash flow improved significantly in 2025 with $472M operating cash flow.
DLB presents a mixed outlook with strong fundamentals but technical weakness. The 47% upside to $90.33 consensus target offers potential, though near-term execution risks and licensing volatility remain concerns. Revenue stability around $1.3B and premium valuation metrics require continued innovation execution to justify current multiples.
Centrus Energy (LEU) trades at $147.14, down 4.38% on the day, amid neutral technical signals and mixed earnings performance. The stock shows elevated valuation ratios with a P/E of 75.18 and P/S of 6.68, while profitability metrics include a 10.23% net income margin and 8.05% ROE. Recent news highlights Centrus' strategic positioning as a key supplier of High-Assay Low-Enriched Uranium (HALEU) for advanced nuclear reactors, supported by new multi-year supply contracts with Antares and Radiant announced in September 2026.
The investment case balances strong growth potential in the nuclear fuel market against execution risks and high valuation. Analyst consensus suggests 46% buy ratings with a $218.10 price target, implying significant upside, but investors face risks from cash flow volatility, competitive pressures, and the company's reliance on successful capacity expansion. The recent $500 million stock offering provides capital for growth but may dilute existing shareholders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →
